DXSE.DE vs. PPH
Compare and contrast key facts about Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) and VanEck Vectors Pharmaceutical ETF (PPH).
DXSE.DE and PPH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. DXSE.DE is a passively managed fund by Xtrackers that tracks the performance of the MSCI Europe Health Care ESG Screened 20-35. It was launched on Jun 26, 2007. PPH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Pharmaceutical 25 Index. It was launched on Dec 20, 2011. Both DXSE.DE and PPH are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DXSE.DE or PPH.
Key characteristics
DXSE.DE | PPH | |
---|---|---|
YTD Return | 10.03% | 13.38% |
1Y Return | 13.97% | 21.87% |
3Y Return (Ann) | 5.05% | 8.06% |
5Y Return (Ann) | 8.10% | 10.76% |
10Y Return (Ann) | 7.58% | 5.55% |
Sharpe Ratio | 1.11 | 1.82 |
Sortino Ratio | 1.59 | 2.54 |
Omega Ratio | 1.19 | 1.32 |
Calmar Ratio | 1.15 | 1.95 |
Martin Ratio | 4.17 | 7.07 |
Ulcer Index | 3.51% | 2.74% |
Daily Std Dev | 13.22% | 10.67% |
Max Drawdown | -34.30% | -46.49% |
Current Drawdown | -11.92% | -8.13% |
Correlation
The correlation between DXSE.DE and PPH is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
DXSE.DE vs. PPH - Performance Comparison
In the year-to-date period, DXSE.DE achieves a 10.03% return, which is significantly lower than PPH's 13.38% return. Over the past 10 years, DXSE.DE has outperformed PPH with an annualized return of 7.58%, while PPH has yielded a comparatively lower 5.55% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
DXSE.DE vs. PPH - Expense Ratio Comparison
DXSE.DE has a 0.17% expense ratio, which is lower than PPH's 0.36% expense ratio.
Risk-Adjusted Performance
DXSE.DE vs. PPH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DXSE.DE vs. PPH - Dividend Comparison
DXSE.DE has not paid dividends to shareholders, while PPH's dividend yield for the trailing twelve months is around 1.76%.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VanEck Vectors Pharmaceutical ETF | 1.76% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% | 1.71% | 2.03% |
Drawdowns
DXSE.DE vs. PPH - Drawdown Comparison
The maximum DXSE.DE drawdown since its inception was -34.30%, smaller than the maximum PPH drawdown of -46.49%. Use the drawdown chart below to compare losses from any high point for DXSE.DE and PPH. For additional features, visit the drawdowns tool.
Volatility
DXSE.DE vs. PPH - Volatility Comparison
Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) has a higher volatility of 3.73% compared to VanEck Vectors Pharmaceutical ETF (PPH) at 3.32%. This indicates that DXSE.DE's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.